MedTrace Logo

Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma

NCT02802124 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-07

No results posted yet for this study

Summary

The aim of this research project is to assess the feasibility and safety of carbon-ion radiotherapy for the treatment of localized Chinese hepatocellular carcinoma

Conditions

Interventions

RADIATION

carbon-ion radiotherapy for tumor away from GI

RADIATION

carbon-ion radiotherapy for tumor adjacent to GI

Sponsors & Collaborators

  • Shanghai Proton and Heavy Ion Center

    lead OTHER

Principal Investigators

  • guoliang Jiang, Prof. · Shanghai Proton and Heavy Ion Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02802124 on ClinicalTrials.gov